Basics |
Hyperfine, Inc.
|
IPO Date: |
January 28, 2021 |
Sector: |
HYPR |
Industry: |
Medical Devices |
Market Cap: |
$51.37M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.08 | 4.57%
|
Avg Daily Range (30 D): |
$0.03 | 4.09%
|
Avg Daily Range (90 D): |
$0.04 | 4.46%
|
Institutional Daily Volume |
Avg Daily Volume: |
.29M |
Avg Daily Volume (30 D): |
.3M |
Avg Daily Volume (90 D): |
.78M |
Trade Size |
Avg Trade Size (Sh.): |
273 |
Avg Trade Size (Sh.) (30 D): |
542 |
Avg Trade Size (Sh.) (90 D): |
366 |
Institutional Trades |
Total Inst.Trades: |
11 |
Avg Inst. Trade: |
$1.33M |
Avg Inst. Trade (30 D): |
$3.06M |
Avg Inst. Trade (90 D): |
$3.06M |
Avg Inst. Trade Volume: |
.59M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$1.74M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
530.89K |
|
|
|
|
News |
Jul 16, 2024 @ 2:00 PM
Hyperfine (HYPR) to Release ACTION PMR Study Data ...
Source: N/A
|
May 28, 2024 @ 12:19 PM
Why You Should Bet on 5 Top-Ranked Stocks With Ris...
Source: Sanghamitra Saha
|
May 13, 2024 @ 9:15 PM
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Reven...
Source: Zacks Equity Research
|
May 13, 2024 @ 8:05 PM
Hyperfine, Inc. Reports First Quarter 2024 Financi...
Source: Hyperfine, Inc.
|
May 6, 2024 @ 2:00 PM
Will Hyperfine, Inc. (HYPR) Report Negative Earnin...
Source: Zacks Equity Research
|
Financials |
|
TTM |
Q1 2025 |
Q4 2024 |
Basic EPS
|
$-.54
|
$-.12
|
$-.14
|
Diluted EPS
|
$-.54
|
$-.12
|
$-.14
|
Revenue
|
$ 11.73M
|
$ 2.14M
|
$ 2.32M
|
Gross Profit
|
$ 5.42M
|
$ .88M
|
$ .83M
|
Net Income / Loss
|
$ -40.29M
|
$ -9.42M
|
$ -10.39M
|
Operating Income / Loss
|
$ -43.48M
|
$ -10.9M
|
$ -10.77M
|
Cost of Revenue
|
$ 6.31M
|
$ 1.25M
|
$ 1.5M
|
Net Cash Flow
|
$ -29.67M
|
$ -4.14M
|
$ -8.31M
|
PE Ratio
|
|
|
|
Splits |
Aug 13, 2003:
1:10
|
|